ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TPTH Tripath Imaging

0.00
0.00 (0.00%)
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Tripath Imaging NASDAQ:TPTH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

TriPath Imaging to Host Second Quarter 2006 Results Conference Call

18/07/2006 10:34pm

PR Newswire (US)


Tripath Imaging (NASDAQ:TPTH)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Tripath Imaging Charts.
BURLINGTON, N.C., July 18 /PRNewswire-FirstCall/ -- TriPath Imaging, Inc. (NASDAQ:TPTH) announced today that it will host a conference call to discuss the Company's second quarter 2006 financial results on Thursday, July 27, 2006 at 11:00 a.m. ET. The financial results will be released prior to market open on July 27, 2006. The call will be available by dialing (888) 344-3716. International participants should call (706) 634-4926. For interested parties unable to participate during the live call, a telephone replay will be available beginning two hours after the completion of the call until August 3, 2006. To access this replay, U.S. participants should call (800) 642-1687. International participants should call (706) 645-9291. Individuals accessing the replay must enter the conference call ID number 3254252. A live web cast and replay of TriPath Imaging's call will also be available online at http://www.tripathimaging.com/. TriPath Imaging, Inc., headquartered in Burlington, North Carolina, develops, manufactures, markets and sells innovative solutions to improve the clinical management of cancer, including detection, diagnosis, staging and treatment. TriPath Oncology, a wholly owned subsidiary of TriPath Imaging, develops molecular diagnostic products for malignant melanoma and cancers of the cervix, breast, ovary and prostate. Additional company information is available at http://www.tripathimaging.com/. Contact Stephen P. Hall Chief Financial Officer 336-290-8721 DATASOURCE: TriPath Imaging, Inc. CONTACT: Stephen P. Hall, Chief Financial Officer of TriPath Imaging, Inc., +1-336-290-8721 Web site: http://www.tripathimaging.com/

Copyright

1 Year Tripath Imaging Chart

1 Year Tripath Imaging Chart

1 Month Tripath Imaging Chart

1 Month Tripath Imaging Chart

Your Recent History

Delayed Upgrade Clock